Recent Clinical Trials in Acute Severe Ulcerative Colitis: Can We Improve the Chances of Success of Corticosteroids and Rescue Therapies?
Canadian IBD Today · 01.05.2026 · 15-21
DOI: 10.58931/cibdt.2026.4154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian IBD Today, online erschienen am 01.05.2026. Verfasst von Thilini Delungahawatta und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Key Takeaways 1. Don’t withhold intravenous (IV) steroids waiting for the stool infectious workup to come back. Many patients with infectious etiologies for exacerbation will require antimicrobials plus steroids to manage severe relapses. 2. When considering infliximab rescue therapy, a 10 mg/kg dose likely leads to higher response rates among patients with hypoalbuminemia (
Zitieren
APA
Delungahawatta, T., & Narula, N. (2026). Recent Clinical Trials in Acute Severe Ulcerative Colitis: Can We Improve the Chances of Success of Corticosteroids and Rescue Therapies?. Canadian IBD Today, 15-21. https://doi.org/10.58931/cibdt.2026.4154
Vancouver
Delungahawatta T, Narula N. Recent Clinical Trials in Acute Severe Ulcerative Colitis: Can We Improve the Chances of Success of Corticosteroids and Rescue Therapies?. Canadian IBD Today. 2026:15-21. doi:10.58931/cibdt.2026.4154
BibTeX
@article{Delungahawatta2026,
author = {Delungahawatta, Thilini and Narula, Neeraj},
title = {Recent Clinical Trials in Acute Severe Ulcerative Colitis: Can We Improve the Chances of Success of Corticosteroids and Rescue Therapies?},
journal = {Canadian IBD Today},
year = {2026},
pages = {15--21},
doi = {10.58931/cibdt.2026.4154}
}
EUVIMED